Component of European Patent 0 808 138. AGA Medical decided to appeal from this decision. The U.K. Court of Appeal in London announced its decision confirming having said that Figulla ASD and PFO occluders do not infringe stated patent. AGA asked for permission to appeal to the Supreme Courtroom , but that program was refused. It is now available to AGA to make a credit card applicatoin direct to the Supreme Courtroom for permission to appeal, but permission sparingly is granted just, such as in situations that involve a point of law of general public importance. Tor Peters, CEO of Occlutech says; ‘We have become pleased with the courts decision that again brings clarity to Occlutech’s position that our exclusive patented braiding technology can be fundamentally different from the older technology.Eat better. Lose fat. How about committing to better oral health? The Academy of General Dentistry’s consumer Web portal,, is a great place to start. The portal is loaded with valuable info, from pertinent problems affecting children, teens, adults and seniors to where to find a general dentist. Dental trends and treatments are continuously changing and improving, says AGD President David F. Halpern, DMD, FAGD. helps consumers stick to the leading edge of what’s new and what’s best for their teeth’s health.